12:30 PM EDT, 09/05/2024 (MT Newswires) -- Qualigen Therapeutics ( QLGN ) shares fell 18% in recent Thursday trading after the company priced a public offering of shares and warrants for gross proceeds of $3.46 million.

About 14.7 million shares were priced at $0.13 apiece and prefunded warrants to purchase up to 12 million shares were priced at $0.129 apiece, the company said Thursday in a statement.

The company plans to use the proceeds for operations and other general corporate purposes, including senior note payments.

The offering is set to close around Friday.

Price: 0.15, Change: -0.03, Percent Change: -18.36